Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells

Chemoresistance mechanisms of colorectal cancer remain largely elusive. We aim to compare the difference of chemotherapy responses between FOLFOX-resistant and wild-type colorectal cancer cells by proteomic profiling to suggest novel treatment targets. FOLFOX-resistant colorectal cancer cells DLD1-R...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Shing-Yau, Islam Khan, Md Zahirul, Chen, Ju-Yu, Yip, Jerica Hiu-Yui, Yan, Hong-Yiu, Tam, Tsz-Yan, Law, Helen Ka-Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298463/
https://www.ncbi.nlm.nih.gov/pubmed/37373047
http://dx.doi.org/10.3390/ijms24129899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298463/
https://www.ncbi.nlm.nih.gov/pubmed/37373047
http://dx.doi.org/10.3390/ijms24129899

Ejemplares similares